Towards Healthcare
Stem Cell Banking Market Size Skyrockets at 16.14% CAGR in 2025

Stem Cell Banking Market Dynamics in 2025 Driven by Adipose and Cord Blood Stem Cells Across Therapeutic Use Cases

Projections indicate that, the global stem cell banking market will increase from USD 7.85 billion in 2024 to USD 35.12 billion by 2034, experiencing a CAGR of 16.14% over the next 10 years. The market is expanding due to the rising prevalence of chronic diseases and growing public awareness of stem cell therapies. Advancements in preservation technologies and increased investment in regenerative medicine further drive the market growth.

Content

  • Insight Code: 5867
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The stem cell banking market is projected to reach USD 35.12 billion by 2034, growing at a CAGR of 16.14% from 2024 to 2034.

North America is currently leading the stem cell banking market due to its advanced healthcare infrastructure, high public awareness, and significant investments in biotechnology.

The stem cell banking market includes six segments by type of stem cell, by service type, by type of bank, by application, by end use, and by region.

Some key players include Neostem, Future Health Biobank, AMAREX Clinical Research, Insception Lifebank, California Cryobank, Umbilical Cord Blood Bank Ltd, and Lonza Group AG.

Key trends include the growth due to the rising prevalence of chronic diseases and growing public awareness of stem cell therapies.

Stored stem cells may be used in the future to treat certain genetic, blood, immune, or metabolic disorders in the child or family members. They serve as a biological insurance.

Research shows stem cells can be cryopreserved and remain viable for over 20 years, with ongoing studies exploring even longer durations.

India Brand Equity Foundation, Food and Drug Administration, U.S. Environmental Protection Agency, European Medicines Agency, and National Medical Products Administration.
Any Questions